CEO Dr. Hanadie Yousef represents Juvena on 2 panels at BIO San Diego to discuss navigating the frontiers of First-in-Class therapeutics, and how healthspan promoting therapeutics are entering the biopharma mainstream.
Juvena is selected by the World Economic Forum to join its 2024 global cohort of Technology Pioneers, awarded to the 100 most innovative tech startups applying new breakthroughs in AI to solve some of the biggest challenges of our time.
Juvena’s SVP of Translation, Dr. Mo Tabrizi participates in the Seattle Myotonic Dystrophy Regional Summit, where Juvena gave an industry presentation.
Juvena’s CEO Dr. Hanadie Yousef participates in the LA Myotonic Dystrophy Regional Summit, where Juvena gave an industry presentation.
InVivo spotlights CEO and Co-Founder Dr. Hanadie Yousef’s Journey with Juvena Therapeutics
Jeanne Jew, MBA
- Former CBO ALX Oncology
- Former SVP BD, Paratek, KaloBios
- Former VP BD, Onyx
- Former Board member: Catalyst Biosciences
- MBA, Cornell
Learn more about Jeanne
